Scientists have developed a novel therapy that converts existing immune cells within tumors into potent anticancer fighters. This innovative approach utilizes CAR-macrophages, which are adept at infiltrating dense tumors and signaling other immune cells to join the fight. Early clinical trials show promise for treating solid cancers with fewer side effects.
